CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+4.05%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
847
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| 1 |
Broadcom
AVGO
|
$37.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
$30.1M |
| 3 |
Biogen
BIIB
|
$28.3M |
| 4 |
Home Depot
HD
|
$23.7M |
| 5 |
Cisco
CSCO
|
$20.7M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$22.4M |
| 2 |
TJX Companies
TJX
|
$20.9M |
| 3 |
Intuit
INTU
|
$15.7M |
| 4 |
FedEx
FDX
|
$15M |
| 5 |
lululemon athletica
LULU
|
$13.4M |
Sector Composition
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.2% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GG
251
DELISTED
Goldcorp Inc
GG
| $6.34M | 0.1% |
461,723
-3,056
| -0.7% | -$41.9K |
|
|
CBAY
252
DELISTED
Cymabay Therapeutics
CBAY
| $6.31M | 0.1% |
470,000
+225,000
| +92% | +$3.02M |
|
253
Ross Stores
ROST
$49.4B
| $6.27M | 0.1% |
73,949
+42,213
| +133% | +$3.58M |
|
254
Yum China
YUMC
$16.5B
| $6.23M | 0.1% |
162,000
-90,500
| -36% | -$3.48M |
|
255
Puma Biotechnology
PBYI
$253M
| $6.21M | 0.1% |
105,000
+37,000
| +54% | +$2.19M |
|
|
SPPI
256
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $6.17M | 0.1% |
294,500
+109,500
| +59% | +$2.3M |
|
257
Zebra Technologies
ZBRA
$16B
| $6.14M | 0.1% |
42,874
+22,111
| +106% | +$3.17M |
|
258
Suncor Energy
SU
$48.5B
| $6.04M | 0.1% |
148,461
+10,436
| +8% | +$424K |
|
259
PVH
PVH
$4.22B
| $5.92M | 0.09% |
39,520
-6,638
| -14% | -$994K |
|
260
Newmont
NEM
$83.7B
| $5.9M | 0.09% |
156,494
-906
| -0.6% | -$34.2K |
|
261
Bio-Rad Laboratories Class A
BIO
$8B
| $5.89M | 0.09% |
20,400
+2,900
| +17% | +$837K |
|
262
APA Corp
APA
$8.14B
| $5.84M | 0.09% |
124,899
-126,483
| -50% | -$5.91M |
|
263
Marsh & McLennan
MMC
$100B
| $5.82M | 0.09% |
70,990
+6,829
| +11% | +$560K |
|
264
Veeco
VECO
$1.47B
| $5.81M | 0.09% |
407,647
+63,188
| +18% | +$900K |
|
265
Kinder Morgan
KMI
$59.1B
| $5.81M | 0.09% |
328,605
-120,334
| -27% | -$2.13M |
|
266
Magna International
MGA
$12.9B
| $5.78M | 0.09% |
99,437
-98,300
| -50% | -$5.71M |
|
|
ESRX
267
DELISTED
Express Scripts Holding Company
ESRX
| $5.68M | 0.09% |
73,562
-128,510
| -64% | -$9.92M |
|
268
S&P Global
SPGI
$164B
| $5.68M | 0.09% |
27,847
-425
| -2% | -$86.7K |
|
269
TG Therapeutics
TGTX
$5.11B
| $5.59M | 0.09% |
425,000
+65,000
| +18% | +$855K |
|
270
Exelixis
EXEL
$10.2B
| $5.59M | 0.09% |
259,500
+36,000
| +16% | +$775K |
|
271
Charles Schwab
SCHW
$167B
| $5.53M | 0.09% |
108,248
+4,092
| +4% | +$209K |
|
272
Blackrock
BLK
$170B
| $5.52M | 0.09% |
11,055
-163
| -1% | -$81.3K |
|
273
PNC Financial Services
PNC
$80.5B
| $5.51M | 0.09% |
40,761
-3,334
| -8% | -$450K |
|
|
PTLA
274
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.5M | 0.09% |
145,700
+25,200
| +21% | +$952K |
|
275
Omnicom Group
OMC
$15.4B
| $5.44M | 0.09% |
71,292
-69,809
| -49% | -$5.32M |
|